BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Numira Biosciences, Inc. Names Hal Widlansky As New CEO


1/9/2014 6:45:15 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Numira Names Hal Widlansky As New CEO

SALT LAKE CITY
, Jan. 9, 2014 /PRNewswire/ -- Numira, a leader in high resolution, 3D imaging services, visualization software, and cloud computing for the life science market, today announced the appointment of Hal Widlansky as Chief Executive Officer.

"We chose Hal not only for his broad background in new technology, but also because of his reputation for aligning organizations to execute on a unified strategy," said Lisa Dunlea, Venture Partner at Signal Peak Ventures and Numira board member. "With Hal, we have found the right CEO to take Numira to the next level, his go-to-market experience is just what the company needs in this next phase of growth."

Prior to taking the helm at Numira, Widlansky served as President and COO of Radiate Media, a digital and broadcast media company recently recognized, for the second consecutive year, as Utah's fastest growing company at the Mountain West Capital Network's (MWCN) Utah 100 Awards. Before Radiate, he served as CEO of Matchbin, a digital media and advertising organization, responsible for the company's acquisition of Nokia's broadcast advertising unit, the merger that would form Radiate Media. Additionally, Hal has served as CEO of Mangia Technologies, a mobile technology company; CEO of SonoMetric Health, a medical software company; and Global Director of SonoSite Ultrasound's cardiology unit.

"Few companies are as well poised for significant growth as Numira," said Hal. "Our focus on execution in product, services, and technology development has established us as a leader in imaging and quantitative analysis for the pharmaceutical and biotech industries. I look forward to working with our phenomenal team in building upon our impeccable reputation and driving growth for our company. I am honored to have been chosen by the board to lead Numira into this next exciting new chapter."

About Numira
Numira is a rapidly growing provider of specialty contract research services to the pharmaceutical and medical device industries. Through the combination of novel software technologies and unique imaging capabilities, Numira provides clients with an unmatched array of pre-clinical services for research programs in inflammation, cardiovascular, oncology, pulmonary, renal, bone, and other therapeutic areas. Numira is a recognized leader in high-resolution imaging and specialized histology services for drug and device development.

For more information visit www.numira.com.

SOURCE Numira



Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES